Abstract
Simultaneous PET/MR imaging is an emerging hybrid modality for clinical and preclinical imaging. The static magnetic field of the MR imaging device affects the trajectory of the positrons emitted by the PET radioisotopes. This effect translates into an improvement of the spatial resolution in transaxial images. However, because of the elongation of the positron range distribution along the magnetic field, the axial resolution worsens and shine-through artifacts may appear. These artifacts can lead to misinterpretation and overstaging. The aim of this work was to study the relevance of this effect. Methods: Measurements were performed in a 3-tesla PET/MR scanner. A 1-cm2 piece of paper, soaked with a radioisotope and placed in air, was scanned, and the magnitude of the shine-through was quantified from the PET images for various radioisotopes. Additionally, PET/MR and PET/CT images of the lungs and the larynx with trachea of a deceased swine were obtained after injecting a mixture of NiSO4 and 68Ga to simulate hot tumor lesions. Results: For the radioactive paper, shine-through artifacts appeared in the location of the acrylic glass backplane, located 3 cm from the source in the axial direction. The ratio between the activity of the shine-through and the activity reconstructed in the original location ranged from 0.9 (18F) to 5.7 (68Ga). For the larynx-with-trachea images, the magnitude of the artifacts depended on the organ orientation with respect to the magnetic field. The shine-through activity could reach 46% of the reconstructed activity (larynx lesion). The lesion within the trachea produced 2 artifacts, symmetrically aligned with the magnetic field and characterized by artifact-to-lesion volume-of-interest ratios ranging from 21% to 30%. Conclusion: In simultaneous PET/MR imaging, the effect of the magnetic field on positrons may cause severe artifacts in the PET image when the lesions are close to air cavities and high-energy radioisotopes are used. For accurate staging and interpretation, this effect needs to be recognized and adequate compensation techniques should be developed.
PET/MR imaging is a powerful technology that is now expanding worldwide (1); integrated PET/MR imaging systems are already commercially available for clinical applications (2,3). Special attention is thus being paid to the ability of simultaneous PET/MR imaging to provide quantitative information and artifact-free images. A particular phenomenon of this integrated technology is the effect of the static magnetic field on positrons. Because of the Lorentz force, positrons follow helical paths along the magnetic field lines. Consequently, the positron range distribution narrows in the plane perpendicular to the magnetic field, thus improving the transaxial resolution (4–9). On the other hand, little attention has been devoted to the behavior of positrons in the axial direction. The positron range distribution elongates along the magnetic field, and the axial resolution subsequently degrades (9–11). The positron range can reach up to a few millimeters in air, and “positron beams” may be created (12). Depending on the lesion location, the strength of the magnetic field, the positron energy, and the density of the surrounding tissues, severe artifacts may distort the image. In addition to axially elongated activity distributions, there may be a shine-through artifact (13–15)—an apparent activity concentration visible in the reconstructed image on the other side of an air cavity, diametrically opposed to the location of the true lesion. Abduhl-Fatah et al. (13) showed that these artifacts were observed in PET/CT because of the large positron range of 124I. In PET/MR imaging, this phenomenon may become more relevant because of the Lorentz force, and the artifacts may also appear for less energetic radioisotopes. It is thus fundamental to identify those scenarios in which positron shine-through may occur, endangering accurate quantification and diagnosis. With this goal in mind, we tested various radioisotopes in different scenarios, including animal tissues, and quantified the apparent activity.
MATERIALS AND METHODS
PET/MR Imaging Scanner
The measurements were performed with a clinical brain PET/MR imaging system (BrainPET, Tim Trio MR; Siemens Healthcare). The PET scanner (16) was mounted inside a 3-tesla MR scanner. The spatial resolution in the center was 2.3, 3.1, and 2.6 mm in full width at half maximum in the x, y, and z directions, respectively (16). Acquired list-mode data were reconstructed using an ordinary Poisson ordered-subsets expectation maximization 3-dimensional algorithm (6 iterations and 16 subsets) (17). The z-axis of the scanner was defined as aligned with the magnetic field. Additional measurements were performed with a clinical PET/CT (18) Hi-Rez Biograph 16 (Siemens Medical Solutions) with a spatial resolution of about 4 mm.
Phantom Measurements
A thin 1-cm2 piece of paper (80 g/m2) was soaked with common PET isotopes (Table 1) and fixed with a surgical fiber into an acrylic glass device (Fig. 1). The device was centered at the field of view, and the paper was placed parallel to the backplane of the device (orthogonal to the magnetic field); the distance between the paper and the backplane was 30 mm. From the reconstructed 3-dimensional images, the percentages of annihilation events that originated on the paper and on the backplane were estimated and a backplane-to-paper ratio was calculated. For this purpose, profiles were extracted from the corresponding coronal planes, and the relative area below the profiles was calculated.
Measurements of Swine Organs
The lungs and the larynx with trachea from a deceased swine were separately fixed onto Styrofoam (The Dow Chemical Co.). A liquid solution consisting of 1 mL of glue, 1 mL of NiSO4, and 0.1 mL of 68Ga was produced. The glue was used to create a high-viscosity medium, whereas the NiSO4 provided a hyperintense MR signal in T1-weighted sequences. The lungs were inflated with oxygen and sealed at the trachea. Three types of lesions were created. To simulate hot pulmonary lesions, the radioactive solution was injected with a syringe in 5 different locations inside the lungs (0.1 mL/lesion); the same volume was applied by submucosal injection into the lower medial part of the epiglottis. Finally, to simulate a tumor with infiltration into the trachea, a thin balloon combined with a catheter was filled with 0.2 mL of the aforementioned solution and placed through a cut within the trachea.
Sequential PET/CT measurements were started with a mean (±SD) residual activity of 272 ± 19 kBq/mL for each lesion with a PET acquisition time of 10 min. CT data were acquired with a low-dose protocol and reconstructed with an isotropic voxel size of 1.0 mm3. Simultaneous PET/MR imaging measurements were performed afterward (10 min/acquisition); the residual activities for the lesions were 110 ± 9 kBq/mL. A 15-min MR imaging sequence followed: localizer, T1-weighted 3-dimensional fast low-angle shot, ultrashort echo, and T1-weighted magnetization-prepared rapid gradient echo. The trachea with larynx was measured at 20° and 35° with respect to the magnetic field. Definition of volumes of interest for each lesion was based on the reconstructed MR images and the PET image with the artifacts. The shine-through effect was quantified as the ratio between the activities within the artifact volume of interest and the true lesion volume of interest (13). The ratio between the activity concentrations in both volumes of interest was also computed.
RESULTS
Phantom Measurements
Table 1 shows the activity ratio between the reconstructed activities in the paper and the backplane. The higher the maximum positron energy, the larger the number of annihilations on the backplane. Even for 18F, a large percentage (47.6%) of the total activity was measured in the backplane. For 68Ga, the apparent activity distribution was 5.7 times higher than the true one.
Measurements of Swine Organs
In the PET/MR images of the lungs (not shown) no shine-through was observed, only a change in the shape of the activity distribution: instead of the spheric shape visible on PET/CT, PET/MR showed the reconstructed lesions as significantly stretched along the magnetic field, whereas the size was contracted in the perpendicular direction.
Data on the trachea with larynx are listed in Table 2, and the corresponding images are shown in Figures 2 and 3. The lesion in the epiglottis is visible in Figure 2, as well as a shine-through artifact at the opposite side of the airway along the magnetic field. The artifact-to-lesion volume-of-interest ratio was 38.8% and 46.6% for the 2 orientations, respectively, which translated into activity concentration ratios of 46.2% and 67.0%. On the other hand, no shine-through was observed in the corresponding PET/CT images. For the trachea (Fig. 3), 2 artifacts were visible in the PET/MR images at the airway boundaries along the magnetic field. The artifact-to-lesion volume-of-interest ratio percentage, averaged over the 2 shine-through lesions, was 20.9% and 29.6% for 20° and 35°, respectively. In all cases, the apparent activity of the shine-through was smaller than the activity in the true lesion.
DISCUSSION
No shine-through was observed in the lungs because of their nonnegligible positron attenuation coefficient. Under the high magnetic field environment of PET/MR, shine-through artifacts were visible when the activity was placed very close to or inside an air cavity. Since these artifacts are a consequence of the helical path of positrons along the magnetic field, the shine-through was identifiable only in sagittal or coronal slices. As expected, the magnitude of the shine-through depended on the radioisotope (i.e., its positron maximum energy), as well as on the distance between the true source and the next tissue boundary: the shorter the path, the more intense the shine-through. Contrary to Abdul-Fatah et al. (13), no artifacts were observed in the PET/CT images, probably due to the shorter positron range of 68Ga than of 124I.
CONCLUSION
In clinical PET/MR, shine-through effects may become relevant when radiopharmaceuticals based on high-energy positron emitters are used and accumulate close to air cavities. In addition to false lesions, the positron shine-through also implies an apparently reduced uptake in the true location. The possible use of 124I for antibody labeling or thyroid imaging, and the increasing interest in 68Ga-labeled somatostatin analogs for PET/MR, makes it necessary to become aware of this potential problem. 68Ga-DOTA peptides are commonly used for patients with meningiomas, which may infiltrate into the paranasal and nasal cavities (19). Given that 68Ga-DOTATOC is also being used for PET/MR-based intensity-modulated radiation therapy planning for meningioma (20), unidentified shine-through artifacts could also lead to irradiation of healthy brain tissue with critical function. Recognition of these artifacts is thus decisive. Additionally, for correct lesion detection, uptake quantification, or dosimetry, there is a need to apply positron-range correction methods able to take into account the density and boundaries of tissues and the effects of the magnetic field.
DISCLOSURE
The costs of publication of this article were defrayed in part by the payment of page charges. Therefore, and solely to indicate this fact, this article is hereby marked “advertisement” in accordance with 18 USC section 1734. This work was financially supported by the German Research Association (DFG) (grant PI771/3-1). No other potential conflict of interest relevant to this article was reported.
Footnotes
Published online Mar. 12, 2015.
- © 2015 by the Society of Nuclear Medicine and Molecular Imaging, Inc.
REFERENCES
- Received for publication August 27, 2014.
- Accepted for publication January 19, 2015.